BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InsiderVincent Milano
This page shows the track record and history of MILANO VINCENT insider trades in BioCryst Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Vincent Milano in BCRX / BioCryst Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-05-20 15,000 6.2500 15,000 6.2500 93,750 350 11.0300 71,700 76.48
2021-11-24 7,500 12.1900 7,500 12.1900 91,425

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Vincent Milano in BCRX / BioCryst Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-03 2025-08-29 4 MILANO VINCENT BCRX Common Stock A - Award D 8.3100 676 6 90,436
2025-06-16 2025-06-12 4 MILANO VINCENT BCRX Common Stock A - Award D 12,500 89,760
2025-06-03 2025-05-30 4 MILANO VINCENT BCRX Common Stock A - Award D 10.7500 523 6 77,260
2025-03-04 2025-02-28 4 MILANO VINCENT BCRX Common Stock A - Award D 8.6100 653 6 76,737
2024-12-02 2024-11-29 4 MILANO VINCENT BCRX Common Stock A - Award D 7.5000 750 6 76,084
2024-09-03 2024-08-30 4 MILANO VINCENT BCRX Common Stock A - Award D 8.6900 647 6 75,334
2024-06-14 2024-06-12 4 MILANO VINCENT BCRX Common Stock A - Award D 6,820 74,687
2024-06-03 2024-05-31 4 MILANO VINCENT BCRX Common Stock A - Award D 6.4600 870 6 67,867
2024-05-22 2024-05-20 4 MILANO VINCENT BCRX Common Stock P - Purchase D 6.2500 15,000 94 66,997
2024-03-04 2024-02-29 4 MILANO VINCENT BCRX Common Stock A - Award D 5.6300 999 6 51,997
2023-12-01 2023-11-30 4 MILANO VINCENT BCRX Common Stock A - Award D 5.8800 956 6 50,998
2023-09-05 2023-08-31 4 MILANO VINCENT BCRX Common Stock A - Award D 7.1100 791 6 50,042
2023-06-15 2023-06-13 4 MILANO VINCENT BCRX Common Stock A - Award D 16,745 49,251
2023-06-02 2023-05-31 4 MILANO VINCENT BCRX Common Stock A - Award D 8.2700 680 6 32,506
2023-03-02 2023-02-28 4 MILANO VINCENT BCRX Common Stock A - Award D 8.8500 635 6 31,826
2022-12-02 2022-11-30 4 MILANO VINCENT BCRX Common Stock A - Award D 13.3600 421 6 31,191
2022-09-02 2022-08-31 4 MILANO VINCENT BCRX Common Stock A - Award D 13.9000 404 6 30,770
2022-06-09 2022-06-07 4 MILANO VINCENT BCRX Common Stock A - Award D 12,866 30,366
2021-11-24 2021-11-24 4 MILANO VINCENT BCRX Common Stock P - Purchase D 12.1900 7,500 91 17,500
2021-07-28 3 MILANO VINCENT BCRX Common Stock D 10,000
2021-07-28 2021-07-26 4 MILANO VINCENT BCRX Non-Qualified Stock Option A - Award D 17.25 66,667 66,667
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)